Empagliflozin attenuates ventricular fibrillation postmyocardial infarction associated with reduced transforming growth factor-1/Smad3 signaling and miR-181a expression
Objective To determine whether empagliflozin reduces ventricular fibrillation and myocardial fibrosis after myocardial infarction via the transforming growth factor-β1/Smad3/miR-181a pathway. Methods Male nondiabetic Sprague–Dawley rats (n = 16) were randomized into sham, myocardial infarction, low-...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2025-07-01
|
| Seri Bilgileri: | Journal of International Medical Research |
| Online Erişim: | https://doi.org/10.1177/03000605251353040 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|